Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

MERIDIAN BIOSCIENCE, INC.

United States·US-MF-000044096

Last updated September 17, 2026

Information

Country
United States
Address
3471, River Hills Drive, Cincinnati (OHIO), United States
LinkedIn
—
Facebook
—
Phone
+1 513.673.8109
PRRC Contact
Susan Bogar
EUDAMED SRN
US-MF-000044096
FDA FEI Number
1524213
DUNS Number
—

Catalogue (235)

Page 2 of 5
DeviceModel / ReferenceRegistriesClassStatus
PREMIER Coccidioides 603096
FDA UDI
Class IIActive
Tru Rsv 751330
FDA UDI
Class IActive
MERIFLUOR GullSORB XX715
FDA UDI
Class IIUnknown
Para-Pak EcoFix / C&S / Clean 331312
FDA UDI
Class IActive
PREMIER H. pylori 606096
FDA UDI
Class IActive
PREMIER Toxins A and B 616096
FDA UDI
Class IActive
Fungal Immunodiffusion Plates - 4 Series 101009
FDA UDI
Class IActive
Para-Pak Modified (Cu) PVA/Formalin 300812
FDA UDI
Class IActive
illumigene Pertussis External Control Kit 279930
FDA UDI
Class IIUnknown
illumigene Group B Streptococcus External Control Kit 279900
FDA UDI
Class IUnknown
Para-Pak SAF/C&S 300412
FDA UDI
Class IUnknown
Para-Pak LV-PVA / 10% Formalin / C&S 330284
FDA UDI
Class IActive
Para-Pak Direct Detect 990125
FDA UDI
Class IActive
Revogene C. difficile 410300
FDA UDI
Class IIActive
MERIFLUOR EBV VCA IgG IFA EB100
FDA UDI
Class IUnknown
Para-Pak Ultra SAF 980212
FDA UDI
Class IUnknown
Para-Pak EcoFix 901312
FDA UDI
Class IActive
Anti-Coccidioides "TP" Control Serum for Immunodiffusion 103101
FDA UDI
Class IIActive
MERIFLUOR Pneumocystis 222030
FDA UDI
Class IIActive
illumigene Mycoplasma Direct External Control Kit 279890
FDA UDI
Class IIUnknown
Alethia™ CMV 481325
FDA UDI
Class IIActive
Alethia™ HSV 1&2 External Control Kit 479960
FDA UDI
Class IIActive
Premier HpSA Flex 619096
FDA UDI
Class IActive
Para-Pak LV-PVA / 10% Formalin 300112
FDA UDI
Class IActive
Alethia Malaria 480925
FDA UDI
Class IIActive
Reagent A (230mL) 960003
FDA UDI
Class IActive
Curian Campy 760730
FDA UDI
Class IActive
PREMIER Cryptococcal Antigen 602096
FDA UDI
Class IIActive
Para-Pak SAF 910212
FDA UDI
Class IActive
Para-Pak Enteric Plus 900812
FDA UDI
Class IActive
Para-Pak 5% Formalin, Non-Buffered Formalin with HCL 901112
FDA UDI
Class IUnknown
Revogene® 610210
FDA UDI
Class IIActive
Premier Ehec 608096
FDA UDI
Class IActive
Revogene® GBS LB 410200
FDA UDI
Class IIUnknown
PREMIER Adenoclone Type 40/41 696006
FDA UDI
Class IActive
PREMIER Platinum HpSA PLUS 601396
FDA UDI
Class IActive
MERIFLUOR EBV-EA IgG IFA EA101
FDA UDI
Class IUnknown
ImmunoCard STAT E. coli O157 Plus 750530
FDA UDI
Class IActive
Para-Pak Ultra EcoFix / C&S / Clean 331612
FDA UDI
Class IUnknown
EcoStain 801400
FDA UDI
Class IUnknown
ImmunoCard STAT! FLU A&B 782030
EUDAMEDFDA UDI
Class IIActive
Para-Pak Zn-PVA / Ultra 10% Formalin 381012
FDA UDI
Class IUnknown
Para-Pak C&S 900612
FDA UDI
Class IActive
Para-Pak Ultra EcoFix 981312
FDA UDI
Class IUnknown
Para-Pak SAF 900212
FDA UDI
Class IActive
illumigene Group A Streptococcus 280150
FDA UDI
Class IIUnknown
Para-Pak 10% Formalin Fixative 9004-01
FDA UDI
Class IActive
Alethia™ HSV 1&2 480650
FDA UDI
Class IIActive
Para-Pak EcoFix/Clean 301312
FDA UDI
Class IActive
Para-Pak LV-PVA 900112
FDA UDI
Class IActive

Related Companies

Authorised Representatives

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (22)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Dec 5, 2025Z-1019-2026—open, classified

The affected lots show a decline in performance over time, which may lead to false-negative results.

Oct 7, 2025Z-0569-2026—open, classified

The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.

Oct 7, 2025Z-0568-2026—open, classified

The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume.

Oct 19, 2023Z-0521-2024—open, classified

Due to a manufacturing defect, certain Para-Pak vials may be at risk for leakage.

Oct 19, 2023Z-0520-2024—open, classified

Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to biological hazards associated with direct contact with the patient specimen.

Oct 19, 2023Z-0519-2024—open, classified

Plastic vials contain a manufacturing defect may cause an increased risk of leakage and presents a risk of incidental exposure to biological hazards associated with direct contact with the patient specimen.

Dec 15, 2022Z-1008-2023—open, classified

Leakage of the original specimen from the plastic microfluidic cartridge (PIE), possibility that laboratory personnel may be exposed to aerosolized specimen containing SARS-CoV-2

Jun 22, 2022Z-1479-2022—open, classified

When a run is aborted, the cooling period protection does not occur and the user is able to open the lid prior to the completion of the cooling period, exposing the user to heated instrument components. Incidental contact with heated instrument components may result in an injury such as minor burns.

Feb 15, 2022Z-0836-2022—open, classified

The photomultiplier tube, may have compromised functionality in some instruments. As a result, the user is likely to observe an increase in false-positive or indeterminate results.

Apr 8, 2021Z-1540-2021—terminated

Emergency Use Application (EUA) application withdrawn as false negative results reported

Apr 8, 2021Z-1541-2021—terminated

Emergency Use Application (EUA) application withdrawn as false negative results reported

Feb 8, 2021Z-1299-2021—terminated

Use of the kits after incorrect storage could lead to a potential false-negative or invalid result. In the event of a false-negative, the incorrect assumption would be made as to the cause of patient symptoms. The appropriate treatment may not be administered, and symptoms may progress. Additional evaluations will be completed and documented within the associated Health Hazard Evaluation.

Dec 17, 2018Z-0732-2019—terminated

An enzyme reagent included in the kit is not maintaining stability through claimed product expiration, resulting in the potential for false negative results when tested with patient specimens and the positive control.

Nov 8, 2016Z-1033-2017—terminated

Internal testing has demonstrated that the indicated kit lots produce false positive results when tested with some broth specimens.

Apr 22, 2014Z-1941-2014—terminated

Illumipro-10 instruments may have Block B chambers operating at an incorrect temperature as a result of incorrect temperature calibration.

Oct 10, 2011Z-0203-2012—terminated

Internal testing has shown that the indicated kits produce false negative results when tested with some direct stool specimens. These false negative reactions are not observed for all devices tested, however, the rate of occurrence will likely impact clinical sensitivity as defined by product registration and associated instructions for use.

Jun 2, 2006Z-1203-06—terminated

The product may produce non-specific reactions with negative specimens and/or the negative control reagent. These non-specific interactions may result in increased invalid test rates and/or positivity rates.

Sep 23, 2003Z-0062-04—terminated

The kits were packaged with incorrect dispensing pipettes.

Jun 18, 2003Z-1127-03—terminated

The Low Positive Standard kit component is losing potency that may result in false positive test results.

Dec 26, 2002Z-0465-03—terminated

Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.

Dec 26, 2002Z-0463-03—terminated

Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.

Dec 26, 2002Z-0464-03—terminated

Due to defective packaging, the firm cannot assure product stability through the labeled expiration date.